Analyst Reco. Simcere Pharmaceutical Group Limited

Equities

Delayed Hong Kong S.E. Other stock markets 04:08:20 2024-05-14 am EDT			5-day change	1st Jan Change
5.7 ^HKD	-1.55%		-0.18%	-15.30%

Apr. 25	Simcere Pharmaceutical’ Profit Down 23% in 2023	MT
Apr. 10	Simcere Pharmaceutical's Cancer Drug Gets Fast Track Designation From US FDA	MT

UBS Adjusts Simcere Pharmaceutical’s Price Target to HK$13 From HK$12.50, Keeps at Buy	22-09-05	MT
UBS Adjusts Simcere Pharmaceutical’s Price Target to HK$12.50 From HK$11.80, Keeps at Buy	22-03-30	MT
SIMCERE PHARMACEUTICAL : Nomura Starts Simcere Pharmaceutical Group at Buy With HK$10.1 Price Target	21-04-19	MT

No results for this search